Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 213.99 USD 1.63% Market Closed
Market Cap: 31.4B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one RMD stock under the Base Case scenario is hidden USD. Compared to the current market price of 213.99 USD, Resmed Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RMD Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

6.4
P/S
P/S
Price to Sales
6.4
vs History
84
vs Industry
20
Median 3Y
7.5
Median 5Y
8.1
Industry
2.1
Forward
6.1
More Details
25.2
P/E
P/E
Price to Earnings
25.2
vs History
95
vs Industry
22
Median 3Y
32.8
Median 5Y
39.2
Industry
21.5
Forward
22.4
More Details
21.3
P/OCF
P/OCF
Price to OCF
21.3
vs History
96
vs Industry
17
Median 3Y
26.2
Median 5Y
34.7
Industry
13.2
More Details
38.8
P/FCFE
P/FCFE
Price to FCFE
38.8
vs History
77
vs Industry
11
Median 3Y
56.2
Median 5Y
60.7
Industry
18.8
More Details
6
P/B
P/B
Price to Book Value
6
vs History
85
vs Industry
11
Median 3Y
7
Median 5Y
8.8
Industry
2
More Details
6.4
EV/S
EV/S
Enterprise Value to Sales
6.4
vs History
85
vs Industry
18
Median 3Y
7.7
Median 5Y
8.3
Industry
2.2
Forward
6.1
More Details
11
EV/GP
EV/GP
Enterprise Value to Gross Profit
11
vs History
87
vs Industry
18
Median 3Y
13.3
Median 5Y
14.7
Industry
4.6
More Details
17.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.6
vs History
93
vs Industry
18
Median 3Y
22.4
Median 5Y
25.9
Industry
11.4
Forward
16.7
More Details
20.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.2
vs History
93
vs Industry
21
Median 3Y
25.9
Median 5Y
30.5
Industry
15.4
Forward
18.3
More Details
21.4
EV/OCF
EV/OCF
Enterprise Value to OCF
21.4
vs History
96
vs Industry
17
Median 3Y
27.1
Median 5Y
35.2
Industry
13
More Details
22.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.8
vs History
96
vs Industry
19
Median 3Y
31
Median 5Y
41.6
Industry
16.5
More Details
4.9
EV/IC
EV/IC
Enterprise Value to IC
4.9
vs History
82
vs Industry
15
Median 3Y
5.3
Median 5Y
5.7
Industry
1.8
More Details

Multiples Across Competitors

RMD Competitors Multiples
Resmed Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Resmed Inc
NYSE:RMD
31.4B USD 6.4 25.2 17.6 20.2
US
Abbott Laboratories
NYSE:ABT
219.7B USD 5.2 16.4 22 32.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.8B USD 21 75.7 58.7 71.1
US
Boston Scientific Corp
NYSE:BSX
138B USD 8.2 74.5 34.1 48.2
US
Stryker Corp
NYSE:SYK
133.6B USD 5.9 44.6 23.2 28
IE
Medtronic PLC
NYSE:MDT
106.4B USD 3.2 25 13.4 18.9
US
Becton Dickinson and Co
NYSE:BDX
58.5B USD 2.8 33.5 14.3 25.8
DE
Siemens Healthineers AG
XETRA:SHL
48.7B EUR 2.1 24.5 14.4 20.5
US
Edwards Lifesciences Corp
NYSE:EW
40.8B USD 7.5 9.8 22.9 25.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
31.9B USD 8.2 35.9 25.6 28.5

See Also

Summary
RMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
RMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RMD stock valuation using valuation multiples.
Wall Street Estimates
RMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 246,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.